IPD
Asset Logo

Impedimed Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

N/A
Annual Growth

5 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

4
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

ImpediMed Ltd. engages in the development and distribution of bioimpedance devices with a focus on medical applications in the fluid status area. The company is headquartered in Brisbane, Queensland and currently employs 73 full-time employees. The company went IPO on 2007-10-24. The firm is engaged in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services with a focus on the early detection of lymphoedema and heart failure. The company measures, monitors and manages fluid status and tissue composition using BIS. The Company’s SOZO digital health platform uses BIS technology to measure and track critical information about the human body to aid clinicians in managing chronic disease and maximizing patient health. Its SFB7 measures fluid status and tissue composition for clinical and research applications. The company offers ImpediVET, a single-channel, tetrapolar BIS device that measures fluid status and tissue composition for veterinary applications from laboratory research to clinic. SOZO applications include L-Dex Analysis for Lymphedema, BodyComp Analysis, Segmental BodyComp analysis, and HF-Dex analysis for heart failure.

📈 Performance

Price History

-72.59%

1M

10Y

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

0%
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.14

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in IPD

4

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in IPD

491 days
IPD investor breakdown
💵 Income of investors

More than 200k

25%

150k - 200k

100k - 150k

25%

50k - 100k

Less than 50k

50%
👶 Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
🙋 Legal gender of investors

Female

25%

Male

75%

Pearlers who invest in IPD also invest in...

CSL Limited

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,000 full-time employees. The Company’s areas of focus and exploration include rare and serious diseases, influenza vaccines, plasma collection, and therapies for iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment manufactures, markets, and distributes plasma therapies (plasma products and recombinants). CSL Seqirus segment manufactures, markets, and distributes primarily influenza-related products and provides pandemic services to governments. The Company’s CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency, dialysis and nephrology and rare diseases. The Company’s geographical areas of operation include Australia, the United States of America, Germany, the United Kingdom, Switzerland, and China. CSL’s products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.

📊 Share price

$308.11 AUD

NULL HEALTH

Find Out More

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

📊 Share price

$34.01 AUD

NULL US

NULL EX AUSTRALIA

NULL BETA

IVV.AX was created on 2000-05-15 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.

📊 Share price

$43.11 AUD

NULL US

NULL EX AUSTRALIA

NULL BETA

ETHI

ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.

📊 Share price

$12.45 AUD

NULL GLOBAL

NULL SMART BETA

NULL ETHICAL

NULL EX AUSTRALIA

ESGI

ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.

📊 Share price

$29.97 AUD

NULL GLOBAL

NULL SMART BETA

NULL ETHICAL

NULL THEMATIC

Want more shares? Try these...

IPD Group Ltd. engages in the servicing industry. The company is headquartered in Sydney, New South Wales. The company went IPO on 2021-12-17. The firm operates through two segments: products division and services division. Products division is engaged in the sale of electrical infrastructure products to customers, including switchboard manufacturers, electrical wholesalers, electrical contractors, power utilities, original equipment manufacturers (OEMs), and system integrators. Its five key categories of products include power distribution, industrial and motor control, automation and industrial communication, power monitoring, and electric vehicle solutions. The company also provides a range of value-added services, including custom assembly, sourcing, engineering design, technical compliance, procurement, transport, technical support, packaging, and labelling. Services division is engaged in provision of services, including installation and commissioning, calibration and testing, maintenance, and repairs and refurbishment.

📊 Share price

$3.73 AUD

IPH Ltd. is a holding company, which engages in the provision of intellectual property services. The company is headquartered in Sydney, New South Wales and currently employs 900 full-time employees. The company went IPO on 2014-11-19. The firm offers a range of IP services and products to a diverse client base including companies, multi-nationals, universities, public sector research organizations, foreign associates and other corporate and individual clients. The firm operates through four segments: Intellectual Property Services Australia & New Zealand; Intellectual Property Services Asia; Intellectual Property Services Canada and Adjacent Businesses. The company operates an international intellectual property services group, comprising a network of member firms working in nine IP jurisdictions and servicing more than 25 countries. The group includes IP firms AJ Park, Griffith Hack, Pizzeys, Smart & Biggar, Spruson & Ferguson and online IP services provider Applied Marks.

📊 Share price

$7.94 AUD

IPB Petroleum Ltd. is an oil and gas exploration company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2013-04-30. The firm has a 100% interest in the petroleum exploration permits located in the Browse Basin (WA-424-P). The Browse Basin is located north of Broome, offshore, Western Australia, and covers an area of approximately 140,000 square kilometers. The WA-424-P permit contains three wells, Gwydion-1, Caspar-1A and Pryderi-1. The Company’s subsidiaries include IPB WA 424P Pty Ltd and IPB Exploration Pty Ltd.

📊 Share price

$0.01 AUD

Imperial Pacific Ltd. engages in the provision of investment and financial services. The company is headquartered in Sydney, New South Wales. The firm is focused on providing productive management input to related parties in which it has a strategic equity interest. The firm's subsidiary, Imperial Pacific Asset Management manages the portfolio of London City Equities. Its wholly owned subsidiaries include Imperial Pacific Fund Managers Pty Limited and Imperial Pacific Resources Pty Limited.

📊 Share price

$1.35 AUD
Compare
Add to watchlist